New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model

Molecular Pharmaceutics

Volumn 10, Issue 9, 2013, Pages 3285-3295

  Grandvuinet, Anne Sophie ^a   Gustavsson, Lena ^b   Steffansen, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

BCRP; Caco 2 cells; Drug interactions; Estrone 3 sulfate; Intestinal membrane transporters; OATP2B1; OST

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; COMPLEMENTARY DNA; DEXAMETHASONE; ESTRONE SULFATE; FLUINDOSTATIN; GENOMIC DNA; ORGANIC ANION TRANSPORTER 2; ORGANIC SOLUTE TRANSPORTER; RNA; SPIRONOLACTONE; TAUROCHOLIC ACID; TRITIUM; UBIQUITIN C; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; DRUG INTERACTIONS; ESTRONE; HUMANS; MEMBRANE TRANSPORT PROTEINS; TAUROCHOLIC ACID;

EID: 84883591789     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300618a     Document Type: Article

References (49)

1. Artursson, P.; Palm, K.; Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug Delivery Rev. 2001, 46, 27-43
2. van Breemen, R. B.; Li, Y. Caco-2 cell permeability assays to measure drug absorption Expert Opin. Drug Metab. Toxicol. 2005, 1, 175-185
3. Shah, P.; Jogani, V.; Bagchi, T.; Misra, A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption Biotechnol. Prog. 2006, 22, 186-198
4. Hayeshi, R.; Hilgendorf, C.; Artursson, P.; Augustijns, P.; Brodin, B.; Dehertogh, P.; Fisher, K.; Fossati, L.; Hovenkamp, E.; Korjamo, T.; Masungi, C.; Maubon, N.; Mols, R.; Mullertz, A.; Monkkonen, J.; O'Driscoll, C.; Oppers-Tiemissen, H. M.; Ragnarsson, E. G.; Rooseboom, M.; Ungell, A. L. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories Eur. J. Pharm. Sci. 2008, 35, 383-396
5. Hilgendorf, C.; Ahlin, G.; Seithel, A.; Artursson, P.; Ungell, A. L.; Karlsson, J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines Drug Metab. Dispos. 2007, 35, 1333-1340
6. Maubon, N.; Le, V. M.; Fossati, L.; Audry, M.; Le, F. E.; Bolze, S.; Fardel, O. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR Fundam. Clin. Pharmacol. 2007, 21, 659-663
7. Sai, Y.; Kaneko, Y.; Ito, S.; Mitsuoka, K.; Kato, Y.; Tamai, I.; Artursson, P.; Tsuji, A. Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells Drug Metab. Dispos. 2006, 34, 1423-1431
8. Varma, M. V.; Rotter, C. J.; Chupka, J.; Whalen, K. M.; Duignan, D. B.; Feng, B.; Litchfield, J.; Goosen, T. C.; El-Kattan, A. F. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1 Mol. Pharm. 2011, 8, 1303-1313
9. Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; Hoffmaster, K. A.; Ishikawa, T.; Keppler, D.; Kim, R. B.; Lee, C. A.; Niemi, M.; Polli, J. W.; Sugiyama, Y.; Swaan, P. W.; Ware, J. A.; Wright, S. H.; Yee, S. W.; Zamek-Gliszczynski, M. J.; Zhang, L. Membrane transporters in drug development Nat. Rev. Drug Discovery 2010, 9, 215-236
10. Food and Drug AdministrationDrug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations. Guidance for Industry (Draft), 2012.
11. Zhang, L.; Huang, S. M.; Lesko, L. J. Transporter-mediated drug-drug interactions Clin. Pharmacol. Ther. 2011, 89, 481-484
12. Tamai, I. Oral drug delivery utilizing intestinal OATP transporters Adv. Drug Delivery Rev. 2012, 64, 508-514
13. Koenen, A.; Kroemer, H. K.; Grube, M.; Meyer zu Schwabedissen, H. E. Current understanding of hepatic and intestinal OATP-mediated drug-drug interactions Expert Rev. Clin. Pharmacol. 2011, 4, 729-742
14. Glaeser, H. Importance of P-glycoprotein for drug-drug interactions Handb. Exp. Pharmaco.l 2011, 201, 285-297
15. Grandvuinet, A. S.; Vestergaard, H. T.; Rapin, N.; Steffansen, B. Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions J. Pharm. Pharmacol. 2012, 64, 1523-1694
16. Nies, A. T.; Schwab, M.; Keppler, D. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs Expert Opin. Drug Metab. Toxicol. 2008, 4, 545-568
17. Karlgren, M.; Vildhede, A.; Norinder, U.; Wisniewski, J. R.; Kimoto, E.; Lai, Y.; Haglund, U.; Artursson, P. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions J. Med. Chem. 2012, 55, 4740-4763
18. Matsson, P.; Pedersen, J. M.; Norinder, U.; Bergstrom, C. A.; Artursson, P. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs Pharm. Res. 2009, 26, 1816-1831
19. Xia, C. Q.; Liu, N.; Yang, D.; Miwa, G.; Gan, L. S. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells Drug Metab. Dispos. 2005, 33, 637-643
20. Gram, L. K.; Rist, G. M.; Lennernas, H.; Steffansen, B. Impact of carriers in oral absorption: Permeation across Caco-2 cells for the organic anions estrone-3-sulfate and glipizide Eur. J. Pharm. Sci. 2009, 37, 378-386
21. Grandvuinet, A. S.; Steffansen, B. Interactions between organic anions on multiple transporters in Caco-2 cells J. Pharm. Sci. 2011, 100, 3817-3830
22. Ming, X.; Knight, B. M.; Thakker, D. R. Vectorial Transport of Fexofenadine across Caco-2 Cells: Involvement of Apical Uptake and Basolateral Efflux Transporters Mol. Pharm. 2011, 8, 1677-1686
23. Prime-Chapman, H. M.; Fearn, R. A.; Cooper, A. E.; Moore, V.; Hirst, B. H. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells J. Pharmacol. Exp. Ther. 2004, 311, 476-484
24. Rozen, S.; Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers Methods Mol. Biol. 2000, 132, 365-386
25. Kullak-Ublick, G. A.; Fisch, T.; Oswald, M.; Hagenbuch, B.; Meier, P. J.; Beuers, U.; Paumgartner, G. Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain FEBS Lett. 1998, 424, 173-176
26. Koenen, A.; Kock, K.; Keiser, M.; Siegmund, W.; Kroemer, H. K.; Grube, M. Steroid hormones specifically modify the activity of organic anion transporting polypeptides Eur. J. Pharm. Sci. 2012, 47, 774-780
27. Hirano, M.; Maeda, K.; Matsushima, S.; Nozaki, Y.; Kusuhara, H.; Sugiyama, Y. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin Mol. Pharmacol. 2005, 68, 800-807
28. Gonzalez-Lobato, L.; Real, R.; Prieto, J. G.; Alvarez, A. I.; Merino, G. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C Eur. J. Pharmacol. 2010, 644, 41-48
29. Ahmed-Belkacem, A.; Pozza, A.; Macalou, S.; Perez-Victoria, J. M.; Boumendjel, A.; Di, P. A. Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2) Anticancer Drugs 2006, 17, 239-243
30. Pedersen, J. M.; Matsson, P.; Bergstrom, C. A.; Norinder, U.; Hoogstraate, J.; Artursson, P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2) J. Med. Chem. 2008, 51, 3275-3287
31. Nozawa, T.; Imai, K.; Nezu, J.; Tsuji, A.; Tamai, I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human J. Pharmacol. Exp. Ther. 2004, 308, 438-445
32. Seward, D. J.; Koh, A. S.; Boyer, J. L.; Ballatori, N. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta J. Biol. Chem. 2003, 278, 27473-27482
33. Dawson, P. A.; Hubbert, M.; Haywood, J.; Craddock, A. L.; Zerangue, N.; Christian, W. V.; Ballatori, N. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter J. Biol. Chem. 2005, 280, 6960-6968
34. Suzuki, M.; Suzuki, H.; Sugimoto, Y.; Sugiyama, Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics J. Biol. Chem. 2003, 278, 22644-22649
35. Trotter, P. J.; Storch, J. Fatty acid uptake and metabolism in a human intestinal cell line (Caco-2): comparison of apical and basolateral incubation J. Lipid Res. 1991, 32, 293-304
36. Troutman, M. D.; Thakker, D. R. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers Pharm. Res. 2003, 20, 1200-1209
37. Pavek, P.; Merino, G.; Wagenaar, E.; Bolscher, E.; Novotna, M.; Jonker, J. W.; Schinkel, A. H. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo(4,5-b)pyridine, and transport of cimetidine J. Pharmacol. Exp. Ther. 2005, 312, 144-152
38. Jindrichova, S.; Novakova, O.; Bryndova, J.; Tvrzicka, E.; Lisa, V.; Novak, F.; Pacha, J. Corticosteroid effect on Caco-2 cell lipids depends on cell differentiation J. Steroid Biochem. Mol. Biol. 2003, 87, 157-165
39. Visentin, M.; Chang, M. H.; Romero, M. F.; Zhao, R.; Goldman, I. D. Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1) Mol. Pharmacol. 2012, 81, 134-142
40. Leuthold, S.; Hagenbuch, B.; Mohebbi, N.; Wagner, C. A.; Meier, P. J.; Stieger, B. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters Am. J. Physiol Cell Physiol 2009, 296, C570-C582
41. Shirasaka, Y.; Mori, T.; Shichiri, M.; Nakanishi, T.; Tamai, I. Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites Drug Metab Pharmacokinet. 2012, 27, 360-364
42. Guidelines on the Investigation of Drug Interactions; European Medicines Agency: London, 2012.
43. Nakanishi, T.; Tamai, I. Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs Drug Metab Pharmacokinet. 2012, 27, 106-121
44. Varma, M. V.; Ambler, C. M.; Ullah, M.; Rotter, C. J.; Sun, H.; Litchfield, J.; Fenner, K. S.; El-Kattan, A. F. Targeting intestinal transporters for optimizing oral drug absorption Curr. Drug Metab. 2010, 11, 730-742
45. Rawlings, J. M.; Lucas, M. L.; Russell, R. I. Measurement of jejunal surface pH in situ by plastic pH electrode in patients with coeliac disease Scand. J. Gastroenterol. 1987, 22, 377-384
46. Li, J.; Wang, Y.; Zhang, W.; Huang, Y.; Hein, K.; Hidalgo, I. J. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical BCRP in polarized cell monolayer systems Drug Metab. Dispos. 2012, 40, 2102-2108
47. Shugarts, S.; Benet, L. Z. The role of transporters in the pharmacokinetics of orally administered drugs Pharm. Res. 2009, 26, 2039-2054
48. Yamasaki, Y.; Ieiri, I.; Kusuhara, H.; Sasaki, T.; Kimura, M.; Tabuchi, H.; Ando, Y.; Irie, S.; Ware, J.; Nakai, Y.; Higuchi, S.; Sugiyama, Y. Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans Clin. Pharmacol. Ther. 2008, 84, 95-103
49. Ballatori, N.; Christian, W. V.; Lee, J. Y.; Dawson, P. A.; Soroka, C. J.; Boyer, J. L.; Madejczyk, M. S.; Li, N. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia Hepatology 2005, 42, 1270-1279